Language

English

Publication Date

3-1-2025

Journal

Eurosurveillance

DOI

10.2807/1560-7917.ES.2025.30.11.2500173

PMID

40116035

PMCID

PMC11927073

PubMedCentral® Posted Date

3-20-2025

PubMedCentral® Full Text Version

Post-print

Abstract

We observed shifting trends in tuberculosis (TB) epidemiology in the EU/EEA between 2019 and 2023. In 2023, TB notifications among people of foreign origin increased by 24.6% after decreasing between 2019 and 2020. The majority originated from African and East Mediterranean regions, with a 316.4% upsurge in TB among Ukrainians in 2022-23. Rifampicin-resistant/multidrug-resistant TB increased by ≥ 60% in 2019-23, mainly among Ukrainians. Rapid response to shifting epidemiological patterns is crucial for efficient TB prevention and control within the EU/EEA.

Keywords

Humans, Tuberculosis, Multidrug-Resistant, Emigrants and Immigrants, Antitubercular Agents, Mycobacterium tuberculosis, Tuberculosis, European Union, Male, Female, Adult, Rifampin, Disease Notification, Africa, Middle Aged, Europe, Ukraine, Population Surveillance, tuberculosis, drug resistance, migrants, refugees, asylum seekers

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.